Proto Labs, Inc.
PRLB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.72 | 2.04 | -0.06 | 5.60 |
| FCF Yield | 2.54% | 0.95% | 2.02% | 1.72% |
| EV / EBITDA | 58.52 | 63.86 | 58.10 | 67.46 |
| Quality | ||||
| ROIC | 0.90% | 0.48% | 0.40% | -0.31% |
| Gross Margin | 45.28% | 44.26% | 44.13% | 42.68% |
| Cash Conversion Ratio | 4.03 | 2.39 | 5.11 | -42.81 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.59% | 1.57% | 0.62% | 0.85% |
| Free Cash Flow Growth | 232.95% | -46.74% | 3.97% | -47.80% |
| Safety | ||||
| Net Debt / EBITDA | -5.46 | -6.40 | -6.03 | -6.62 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 5.26 | 5.72 | 5.34 | 5.67 |
| Cash Conversion Cycle | 47.69 | 49.87 | 49.38 | 47.18 |